University of Michigan
In Brief This Week: Hologic, Clinical Microbiomics, Eisai, Biogen, University of Michigan, Dizal
News items for the week of Oct. 14, 2024.
Investigators last month published early results, which they believe have set a solid foundation for the independent value of their novel signature.
Polygenic Risk Score Shows Promise Predicting Beta Blocker Response in Heart Failure Patients
Premium
Researchers from Henry Ford Health in Detroit hope to prospectively validate the pharmacogenomics PRS's ability to predict survival benefit for patients on beta blockers.
Polygenic Risk Scores for Breast, Prostate Cancer Adaptable for Cross-Ancestry Use, Study Shows
The researchers said the approach could be a short-term measure while genetic studies of more diverse ancestral populations are performed.
Drug Combination, Biomarker Search Continues in Urothelial Cancer After Mixed ESMO Trial Data
Premium
Following variable Phase III outcomes, investigators are searching for more informative biomarkers than PD-L1 expression in advanced urothelial carcinoma cases.